PLAU and prostate carcinoma: Equol, applied at concentrations of 10 μM and 50 μM for 24 h, was found to decrease uPA mRNA expression in prostate cancer DU-145 cells, which possess moderate metastatic potential (Zheng et al., 2012[145]) (Figure 1(Fig. 1)).